Title : The benefit of medium-chain triglyceride therapy on the cardiac function of SHRs is associated with a reversal of metabolic and signaling alterations.

Pub. Date : 2008 Jul

PMID : 18456726






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Administration of MCT of SHRs reversed the LCT-induced reduction in the cardiac FA metabolic enzymatic activities of long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) and medium-chain acyl-CoA dehydrogenase (MCAD). N-[5-(4-Nitrophenyl)-1,3,4-thiadiazol-2-yl]acetamide acyl-CoA dehydrogenase medium chain Rattus norvegicus
2 Administration of MCT of SHRs reversed the LCT-induced reduction in the cardiac FA metabolic enzymatic activities of long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) and medium-chain acyl-CoA dehydrogenase (MCAD). N-[5-(4-Nitrophenyl)-1,3,4-thiadiazol-2-yl]acetamide acyl-CoA dehydrogenase medium chain Rattus norvegicus